Pancreatic Cancer Research

ResearcherKliniken Essen-MitteActive in the last 2 years

Michael Ståhl

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7171-9691; OpenAlex author ID A5046222147. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 5

  1. Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection? Co-author DOI 10.1007/s12094-023-03323-1↗
  2. Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades … Co-author DOI 10.1016/j.esmoop.2024.102944↗
  3. Afatinib plus gemcitabine versus gemcitabine alone as first-line treatment of metastatic pancreatic cancer: The randomised, open-label phase II ACCEPT study of… Co-author DOI 10.1016/j.ejca.2020.12.029↗
  4. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEO… Co-author DOI 10.1016/s2468-1253(20)30330-7↗
  5. Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: a subanalysis from… Last author DOI 10.1186/s12885-016-2798-8↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Volker Heinemann · 4 shared papers, 2021–2024 · strength 0.51
  2. Dirk Waldschmidt · 4 shared papers, 2021–2024 · strength 0.51
  3. Stefan Hubert Boeck · 4 shared papers, 2021–2024 · strength 0.51
  4. Michael Haas · 3 shared papers, 2021–2024 · strength 0.43
  5. Anke Reinacher‐Schick · 3 shared papers, 2021–2024 · strength 0.43
  6. Christoph Benedikt Westphalen · 3 shared papers, 2021–2024 · strength 0.43
  7. Jens Thomas Siveke · 3 shared papers, 2021–2024 · strength 0.42
  8. Lena Weiss · 2 shared papers, 2024 · strength 0.33
  9. Klara Dorman · 2 shared papers, 2024 · strength 0.33
  10. Julia V. Mayerle · 2 shared papers, 2024 · strength 0.33
  11. Danmei Zhang · 1 shared paper, 2024 · strength 0.16
  12. Peter Malfertheiner MD · 1 shared paper, 2021 · strength 0.10
  13. Stephan Krüger · 1 shared paper, 2021 · strength 0.10
  14. Thomas Theodor Werner Seufferlein · 1 shared paper, 2021 · strength 0.10
  15. Marcus Bahra · 1 shared paper, 2021 · strength 0.08
  16. Ingo Hartlapp · 1 shared paper, 2021 · strength 0.08
  17. Wolfgang Blau · 1 shared paper, 2021 · strength 0.08
  18. Frank Kullmann · 1 shared paper, 2021 · strength 0.08
  19. Uwe M. Martens · 1 shared paper, 2021 · strength 0.08
  20. Volker Kunzmann · 1 shared paper, 2021 · strength 0.08
  21. Thomas Jens Ettrich · 1 shared paper, 2021 · strength 0.08
  22. Ingo Klein · 1 shared paper, 2021 · strength 0.08
  23. Uwe Pelzer · 1 shared paper, 2021 · strength 0.08
  24. Helmut Friess · 1 shared paper, 2021 · strength 0.08
  25. Hana Algül · 1 shared paper, 2021 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.